Increased activity of matrix metalloproteinases and their tissue inhibitors in cerebrospinal fluid of patients with HTLV-1 associated tropical spastic paraparesis
Ma. Valenzuela et al., Increased activity of matrix metalloproteinases and their tissue inhibitors in cerebrospinal fluid of patients with HTLV-1 associated tropical spastic paraparesis, REV MED CHI, 128(6), 2000, pp. 585-592
Background: Proteolytic modifications of neuronal surfaces and the surround
ing extracellular matrix are ver important in neuronal development and rege
neration. Increased activity of matrix metalloproteinases (MMPs) and their
tissue inhibitors, due to secretion by macrophages and lymphocytes, occur i
n inflammatory processes that disrupt the blood brain barrier. However, neu
rons and microglia can also secrete these enzymes. Aim: To identify the typ
e of MMP present in the cerebrospinal fluid (CSF) and changes in the expres
sion of tissue inhibitors of metalloproteinases (TIMPs) in patients wit HTL
V-1 associated tropical spastic paraparesis. Patients adn methods: CSF samp
les from 12 patients with HTLV-1 associated tropical spastic paraparesis an
d 12 healthy controls were obtained by an atraumatic lumbar puncture. The p
resence of MMPs was measured by zymography and the relative amounts of TIMP
s were measured by immunowestern blot. Results: In the CSF of both controls
and patients, a similar gelatinolytic band corresponding to proMMP-2 (late
nt form) was observed. In 83.3% of patients with HTLV 1 associated tropical
spastic paraparesis, the MMP-9 wa also present. TIMP-1, TIMP-2 and TIMP-3
were elevated 2.24 +/- 0.72, 3.85 +/- 1.38 and 5.89 +/- 3.4 fold, respectiv
ely, in the CSF of patients as compared to controls. Conclusions: Patients
with HTLV-1 associated tropical spastic paraparesis have elevated activity
of MMP-9 and levels of TIMPs in the CSF, when compared to healthy controls.